Rolando Gutierrez Esteinou News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rolando gutierrez esteinou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rolando Gutierrez Esteinou Today - Breaking & Trending Today

atai Life Sciences Announces R&D Day Agenda

NEW YORK and BERLIN, Oct. 20, 2022 (GLOBE NEWSWIRE) atai Life Sciences N.V. (NASDAQ: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders ....

Stephen Bardin , Srinivas Rao , Allan Malievsky , Gerard Sanacora , Rolando Gutierrez Esteinou , Life Sciences Rd Strategy , Exchange Commission , Early Development , Icahn School Of Medicine At Mount Sinai , Yale Depression Research Clinic , Life Sciences , Neokee Pharma Consulting , Yale Interventional Psychiatry Service , Program Updates , Investor Relations , Life Science Rd Day , Pipeline Overview , Regulatory Landscape , Heather Berlin , Clinical Psychologist , Associate Clinical Professor , Icahn School , Yale School , Depression Research Clinic , Interventional Psychiatry , Chief Scientific Officer ,

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces R&D Day Agenda

Investegate announcements from atai Life Sciences, atai Life Sciences Announces R&D Day Agenda ....

Stephen Bardin , Srinivas Rao , Allan Malievsky , Gerard Sanacora , Rolando Gutierrez Esteinou , Life Sciences Rd Strategy , Exchange Commission , Yale Depression Research Clinic , Early Development , Icahn School Of Medicine At Mount Sinai , Life Sciences , Neokee Pharma Consulting , Life Sciences Announces Rd Day Agenda , Yale Interventional Psychiatry Service , Program Updates , Life Sciences Announces Rd Day , Investor Relations , Life Science Rd Day , Pipeline Overview , Florian Brand , Regulatory Landscape , Heather Berlin , Clinical Psychologist , Associate Clinical Professor , Icahn School , Yale School ,

atai Life Sciences Appoints New Chief Financial Officer and Chief Medical Officer

Published: Dec 16, 2020
NEW YORK, Dec. 16, 2020 /PRNewswire/
atai Life Sciences ( atai or the Company ), a global biotech company developing psychedelic and non-psychedelic compounds for various mental health indications, has announced the appointment of Greg Weaver as Chief Financial Officer (CFO) and Rolando Gutierrez-Esteinou as Chief Medical Officer (CMO).
Mr. Weaver joins atai with extensive experience in finance, having held numerous executive positions in the field of biotechnology. Greg s career has focused on start-up through clinical development and commercial stage. He has guided over $1.1 billion in financing transactions during his career, participated in several public and private financings, providing financial guidance, strategic leadership and shareholder value. Prior to joining atai, Mr. Weaver was CFO at several successful companies, including SIRNA Therapeutics, ILEX Oncology, Oryzon, Prometic, and Eloxx Pharmaceuticals. ....

New York , United States , San Diego , New Jersey , Universidad Nacional Autonoma , Anne Donohoe , Srinivas Rao , Rolando Gutierrez Esteinou , Trinity University , Eloxx Pharmaceuticals , Harvard Medical School , National Institute Of Mental Health , Strategic Communications , Life Sciences , Greg Weaver , Chief Financial Officer , Chief Medical Officer , Co Founder Florian , Boston College , Graduate School , Chief Scientific , Universidad Nacional Autonoma De Mexico , Harvard Medical , National Institute , Mental Health , Chief Financial ,